Breast cancer antigens
US7335467B2 · kind B2 · utility
1Cited by
0References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 15, 2002 |
| Grant date | Feb 26, 2008 |
| Priority date | — |
| Expiry date | May 2, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/25
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides methods for diagnosing cancer including breast cancer, based on the identification of certain breast cancer-associated polypeptides as antigens that elicit immune responses in breast cancer. The identified antigens can be utilized as markers for diagnosing breast cancer, and for following the course of treatment of breast cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.